People: Amgen Inc (AMGN.O)
AMGN.O on Nasdaq
105.91USD
24 May 2013
105.91USD
24 May 2013
Price Change (% chg)
$0.29 (+0.27%)
$0.29 (+0.27%)
Prev Close
$105.62
$105.62
Open
$105.10
$105.10
Day's High
$106.17
$106.17
Day's Low
$104.37
$104.37
Volume
2,410,950
2,410,950
Avg. Vol
4,204,169
4,204,169
52-wk High
$114.95
$114.95
52-wk Low
$67.61
$67.61
Peacock, Jonathan
Brief Biography
Mr. Jonathan M. Peacock is Chief Financial Officer, Executive Vice President of Amgen Inc., since September 2010. Prior to joining Amgen and beginning in 2005, Mr. Peacock served as Chief Financial and Administration Officer of Novartis Pharmaceuticals AG, a healthcare company based in Switzerland. From 1998 to 2005, Mr. Peacock was a partner at McKinsey and Co., where he co-led the firm's European Corporate Finance Practice. Mr. Peacock was also a partner at Price Waterhouse in London and New York from 1993 to 1998.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 878,931 | -- | 1,855,590 | 6,277,430 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Robert Bradway |
13,570,100 |
Jonathan Peacock |
6,277,430 |
Madhavan Balachandran |
-- |
Sean Harper |
6,089,760 |
Anthony Hooper |
8,585,990 |
Cynthia Patton |
-- |
As Of 30 Dec 2012

